Merck Insomnia Drug Carries Risks of Drowsy Driving, Suicidal Thoughts
Posted on 05/20/2013 by Associated Press | General News | Comments
Bulletin Today | Personal HealthBy Matthew Perrone, AP Health Writer WASHINGTON (AP) — Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. Related: ER Visits Soar for Older Adults Taking Ambien The Food and Drug Administration on Monday released its review of the company’s sleep aid, suvorexant, ahead of a public meeting on Wednesday. The pill works by temporarily blocking chemical messengers that keep people …
